Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...

The PCMPA has slammed Moderna over an unapproved WhatsApp message that offered children 1,500 pounds sterling ($2,000) to ...

GSK's decision not to advance the vaccine into Phase III trials ends its ambition to bring the first HSV vaccine to market.

With the approval of Moderna's updated COVID-19 vaccine, doctors are hoping the shots will be available soon and Albertans ...

Under the EU Clinical Trials Regulation, financial incentives are not allowed for participants under 16 to prevent undue ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Novavax uses a protein-based vaccine strategy, which means people getting the vaccine receive a protein made by the virus ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

This means adults have a choice in which COVID vaccine they receive: an mRNA vaccine by Moderna or Pfizer, or Novavax, a protein-based vaccine that targets the virus in a more "traditional" way.